Table 3. Medication use of the female and male patients who received AAD surgery before propensity score matching.

	Type A open				Type B stent
Variable	Female (n = 1,286)	Male (n = 2,883)	P	STD	Female (n = 124)	Male (n = 549)	P	STD
Post OP anti-HTN medication
ACEi/ ARB	429 (33.4)	957 (33.2)	0.917	<0.01	52 (41.9)	255 (46.4)	0.362	-0.09
Beta blocker	642 (49.9)	1,598 (55.4)	<0.001	-0.11	57 (46.0)	304 (55.4)	0.058	-0.19
CCB	474 (36.9)	1,135 (39.4)	0.124	-0.05	54 (43.5)	250 (45.5)	0.688	-0.04
Alpha-blocker	59 (4.6)	221 (7.7)	<0.001	-0.13	11 (8.9)	65 (11.8)	0.345	-0.10
Thiazide	46 (3.6)	75 (2.6)	0.083	0.06	9 (7.3)	15 (2.7)	0.014	0.21
Loop diuretics	327 (25.4)	643 (22.3)	0.027	0.07	18 (14.5)	56 (10.2)	0.165	0.13
Spironolactone (Potassium-sparing)	54 (4.2)	74 (2.6)	0.005	0.09	2 (1.6)	7 (1.3)	0.767	0.03
Vasodilator	184 (14.3)	388 (13.5)	0.461	0.02	20 (16.1)	111 (20.2)	0.299	-0.11
Nitrate	137 (10.7)	286 (9.9)	0.469	0.02	16 (12.9)	85 (15.5)	0.468	-0.07
Number of anti-HTN drugs	1.8 ± 1.6	1.9 ± 1.6	0.540	-0.02	2.0 ± 1.7	2.1 ± 1.5	0.300	-0.10
Post OP other medication
Statin	63 (4.9)	116 (4.0)	0.198	0.04	8 (6.5)	59 (10.7)	0.149	-0.15
Antiplatelet	227 (17.7)	511 (17.7)	0.955	<0.01	31 (25.0)	167 (30.4)	0.232	-0.12
Anticoagulant	150 (11.7)	401 (13.9)	0.048	-0.07	1 (0.8)	15 (2.7)	0.204	-0.15
OHA	110 (8.6)	103 (3.6)	<0.001	0.21	16 (12.9)	33 (6.0)	0.008	0.24
Insulin	11 (0.9)	6 (0.2)	0.002	0.09	3 (2.4)	4 (0.7)	0.094	0.14

AAD, acute aortic dissection; STD, standardized difference; OP, operation; HTN, hypertension; ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; OHA, oral hypoglycemic agent.

Value are given as number (%) or mean ± standard deviation.